Washington, D.C.— The U.S.-China Economic and Security Review Commission released its annual report on Tuesday outlining 39 policy recommendations to Congress on addressing the unfair trade practices and anticompetitive actions of the Chinese Communist Party (CCP), with commissioners arguing that significant work remains to safeguard America’s national and economic security.
Commissioners identified 10 of the 39 recommendations as “the most important for congressional action,” including revoking China’s Permanent Normal Trade Relations (PNTR) status, using the Domestic Production Act to re-shore the U.S. production of pharmaceutical goods that depend on active ingredients from China, and establishing a new Economic and Security Preparedness and Resilience Office in the Executive Branch to monitor critical supply chains.
Alliance for American Manufacturing President Scott Paul said:
“From tariffs imposed by the last administration to sharp restrictions in technology transfer prescribed by the Biden administration, policymakers have begun offering bold policy measures to protect American interests against unfair trade practices and other anticompetitive policies put into place by the Chinese Communist Party. The recommendations released today from the U.S.-China Economic and Security Review Commission will build on these initial steps, and we believe policymakers in Congress and the Biden administration should take heed. Suspending normalized trade relations status for China should be a priority for lawmakers. Also of note are recommendations to bolster domestic supply chain resilience and monitor our dependence on pharmaceutical supplies from China.
“We believe there is bipartisan interest in strengthening domestic supply chains and demonstrating global leadership to contain China’s harmful trade and economic policies. Commissioners should be commended for working together to identifying serious challenges and offering actionable and reasonable recommendations to safeguard American security and jobs.”
Click here for the full report.